Profile
| Metric | Value |
|---|---|
| Full Name | Guardant Health, Inc. |
| Ticker | NASDAQ: GH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | guardanthealth.com |
| Employees | 1,999 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $110.17 | |
| Price, 1D Change | +1.32% | |
| Market Cap | $14B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.06 | |
| Revenue | $739M | |
| Revenue, 1Y Change | +31.04% | |
| EPS | -$3.56 | |
| EPS, 1Y Change | +16.96% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$3.56 | |
| EPS Estimate | -$1.81 | |
| EPS Est. Change | +49.17% | |
| Revenue | $739.02M | |
| Revenue Estimate | $968.56M | |
| Revenue Est. Change | +31.06% | |
| Current Price | $110.17 | |
| Price Target | - | $120.00 |
| Price Tgt. Change | - | +8.92% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.59 | -$4.28 | -19.25% | |
| -$1.99 | -$3.56 | -78.95% | |
| -$1.81 | N/A | +49.17% | |
| -$1.44 | N/A | +59.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $563.95M | $563.95M | 0.00% | |
| $729.04M | $739.02M | +1.37% | |
| $968.56M | N/A | +31.06% | |
| $1.23B | N/A | +66.69% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +201.09% | |
| Price, 3Y | +296.44% | |
| Market Cap, 1Y | +215.37% | |
| Market Cap, 3Y | +401.73% | |
| Revenue, 1Y | +31.04% | |
| Revenue, 3Y | +97.78% | |
| EPS, 1Y | +16.96% | |
| EPS, 3Y | +11.21% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $110.17 | |
| SMA 200 | $63.99 | |
| SMA 200 vs Price | -41.92% | |
| SMA 50 | $101.05 | |
| SMA 50 vs Price | -8.28% | |
| Beta | 1.06 | |
| ATR | $4.46 | |
| 14-Day RSI | 63.88 | |
| 10-Day Volatility | 56.14% | |
| 1-Year Volatility | 66.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $739.02M | |
| EPS | -$3.56 | |
| Gross Profit | $449.22M | |
| Gross Margin | 60.79% | |
| Operating Profit | -$443.59M | |
| Operating Margin | -60.03% | |
| Net Income | -$436.37M | |
| Net Margin | -59.05% | |
| EBITDA | -$390.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -8.18 | |
| Current Ratio | 4.68 | |
| Quick Ratio | 4.36 | |
| Interest Coverage | -167.57 | |
| F-Score | 4 | |
| Altman Z-Score | 3.06 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 15.85 | |
| PB Ratio | -40.36 | |
| EV/EBITDA | -37.42 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$139.65M | |
| Cash & Equivalents | $525.54M | |
| Total Assets | $1.49B | |
| Current Assets | $1.06B | |
| Total Liabilities | $1.63B | |
| Current Liabilities | $225.58M | |
| Total Debt | $1.34B | |
| Short Term Debt | $29.21M | |
| Accounts Payable | $38.55M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.18B | |
| Operating Expenses | $892.81M | |
| Cost Of Goods Sold | $289.80M | |
| SG&A | $545.06M | |
| D&A | $42.39M | |
| Interest Expense | $2.58M | |
| Income Tax | $1.28M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$239.86M | |
| CFI | -$261.31M | |
| CFF | -$996.00K | |
| Capex | $35.09M | |
| Free Cash Flow | -$274.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stifel | → | |
| Guggenheim | → | |
| Evercore ISI Group | → | |
| Canaccord Genuity | → | |
| Mizuho | → | |
| Wells Fargo | → | |
| Leerink Partners | → | |
| JP Morgan | → | |
| Barclays | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with GH
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576280/000157628025000277/0001576280-25-000277-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628025000044/0001576280-25-000044-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh
FAQ
What is the ticker symbol for Guardant Health, Inc.?
The ticker symbol for Guardant Health, Inc. is NASDAQ:GH
Does Guardant Health, Inc. pay dividends?
No, Guardant Health, Inc. does not pay dividends
What sector is Guardant Health, Inc. in?
Guardant Health, Inc. is in the Healthcare sector
What industry is Guardant Health, Inc. in?
Guardant Health, Inc. is in the Diagnostics & Research industry
What country is Guardant Health, Inc. based in?
Guardant Health, Inc. is headquartered in United States
When did Guardant Health, Inc. go public?
Guardant Health, Inc. initial public offering (IPO) was on October 4, 2018
Is Guardant Health, Inc. in the S&P 500?
No, Guardant Health, Inc. is not included in the S&P 500 index
Is Guardant Health, Inc. in the NASDAQ 100?
No, Guardant Health, Inc. is not included in the NASDAQ 100 index
Is Guardant Health, Inc. in the Dow Jones?
No, Guardant Health, Inc. is not included in the Dow Jones index
When was Guardant Health, Inc. last earnings report?
Guardant Health, Inc.'s most recent earnings report was on October 29, 2025
When does Guardant Health, Inc. report earnings?
The next expected earnings date for Guardant Health, Inc. is February 19, 2026